BI Asset Management Fondsmaeglerselskab’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.09M | Buy |
13,677
+1,949
| +17% | +$868K | 0.06% | 222 |
|
|
2025
Q1 | $5.69M | Sell |
11,728
-4,593
| -28% | -$2.23M | 0.06% | 218 |
|
|
2024
Q4 | $6.57M | Sell |
16,321
-3,503
| -18% | -$1.41M | 0.07% | 193 |
|
|
2024
Q3 | $9.22M | Sell |
19,824
-39,687
| -67% | -$18.5M | 0.16% | 120 |
|
|
2024
Q2 | $27.9M | Sell |
59,511
-8,997
| -13% | -$4.22M | 0.46% | 51 |
|
|
2024
Q1 | $28.6M | Buy |
68,508
+10,408
| +18% | +$4.35M | 0.54% | 46 |
|
|
2023
Q4 | $23.6M | Sell |
58,100
-3,810
| -6% | -$1.55M | 0.5% | 52 |
|
|
2023
Q3 | $21.5M | Buy |
61,910
+10,673
| +21% | +$3.71M | 0.5% | 54 |
|
|
2023
Q2 | $18M | Sell |
51,237
-5,041
| -9% | -$1.77M | 0.43% | 64 |
|
|
2023
Q1 | $17.7M | Buy |
56,278
+6,231
| +12% | +$1.96M | 0.47% | 57 |
|
|
2022
Q4 | $14.5M | Buy |
50,047
+3,705
| +8% | +$1.07M | 0.39% | 75 |
|
|
2022
Q3 | $13.4M | Sell |
46,342
-7,408
| -14% | -$2.14M | 0.68% | 41 |
|
|
2022
Q2 | $15.1M | Sell |
53,750
-15,296
| -22% | -$4.31M | 0.65% | 46 |
|
|
2022
Q1 | $18M | Sell |
69,046
-9,831
| -12% | -$2.57M | 0.69% | 48 |
|
|
2021
Q4 | $17.3M | Sell |
78,877
-443
| -0.6% | -$97.3K | 0.64% | 51 |
|
|
2021
Q3 | $14.4M | Buy |
79,320
+23,573
| +42% | +$4.28M | 0.55% | 54 |
|
|
2021
Q2 | $11.2M | Sell |
55,747
-5,371
| -9% | -$1.08M | 0.43% | 65 |
|
|
2021
Q1 | $13.1M | Buy |
61,118
+6,851
| +13% | +$1.47M | 0.53% | 59 |
|
|
2020
Q4 | $12.8M | Buy |
54,267
+30,501
| +128% | +$7.21M | 0.56% | 49 |
|
|
2020
Q3 | $6.47M | Buy |
23,766
+5,757
| +32% | +$1.57M | 0.29% | 76 |
|
|
2020
Q2 | $5.23M | Buy |
18,009
+12,128
| +206% | +$3.52M | 0.27% | 86 |
|
|
2020
Q1 | $1.4M | Buy |
5,881
+4,092
| +229% | +$973K | 0.08% | 194 |
|
|
2019
Q4 | $392K | Sell |
1,789
-357
| -17% | -$78.2K | 0.02% | 270 |
|
|
2019
Q3 | $364K | Buy |
2,146
+153
| +8% | +$26K | 0.02% | 310 |
|
|
2019
Q2 | $365K | Buy |
+1,993
| New | +$365K | 0.02% | 190 |
|